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multilocus sequence typing of the isolates would
be required.
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ABSTRACT
In total, 320 vaginal or rectal swabs were cultured
on Granada medium (GM) or Group B Streptococ-
cus Differential Agar (GBSDA), and were also
inoculated into LIM broth (Todd–Hewitt broth
supplemented with selective antibiotics), for
detection of group B Streptococcus (GBS). Overall,
GBS isolates were detected on 53 of the 320 swabs;
47 of these isolates grew on both GM and GBSDA,
five only on GBSDA, and one only following
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subculture from LIM broth. GBSDA appears to be
a valid alternative to GM for the growth of GBS
isolates from pregnant women.
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Streptococcus agalactiae (group B Streptococcus; GBS)
is a significant cause of perinatal and neonatal
infections worldwide [1]. To detect GBS colonisa-
tion in pregnant women, the CDC recommends
isolation of the bacterium from vaginal and ano-
rectal swab samples by growth in a selective
enrichment medium, such as Todd–Hewitt broth
or LIM broth (Todd–Hewitt broth supplemented
with selective antibiotics), followed by subculture
on sheep blood agar [2]; however, this procedure
may require 48 h to complete.
In recent years, modifications of Islam medium,
first described in 1977, have been tested for their
suitability for detecting and isolating GBS [3,4].
Such modified media include Granada medium
(GM) [3,5], on which b-haemolytic strains of
S. agalactiae produce orange-to-salmon colonies
[3], thereby allowing identification of GBS in a
single step. GM shows a sensitivity of > 90% for
the detection of GBS [6–9], although there have
been reports of lower sensitivity [10] that may be
explained by poor storage conditions in the
laboratory or during transportation [11]. How-
ever, the occurrence (1–3%) of non-pigmented
GBS strains, as well as possible masking of the
orange colour in GM by the saprophytic flora that
normally colonises the vagina, make alternative
procedures desirable. The Group B Streptococcus
Differential Agar (GBSDA; BD Biosciences, San
Jose, CA, USA) is a modification of New GM with
improved stability and selectivity. The present
study aimed to assess the performance of GBSDA
in the isolation and identification of GBS, using
GM as the standard for comparison.
Between October and December 2003, 320 swab
samples (68 rectal, 196 vaginal, 56 vagino-
anorectal) were collected from pregnant women
and inoculated, in an antenatal clinic in random
order, on to GM (Biomedics, Madrid, Spain) and
GBSDA, and finally into LIM broth (BD Bioscien-
ces). Plates were incubated under anaerobic con-
ditions at 37C and examined after 24 and 48 h for
red–orange colonies (indicating the presence of
GBS). A pigment-producing S. agalactiae strain,
ATCC 12386, was used as a positive control for
detection of red–orange pigmentation. After incu-
bation for 24 h under anaerobic conditions,
the LIM broth cultures were subcultured on to
Columbia agar containing sheep blood 5% v ⁄ v (BD
Stacker Plates; BBL, Franklin Lakes, NJ, USA) for
detection of colonies showing b-haemolysis.
Colonies with a red–orange appearance on GM
and GBSDA plates, or showing b-haemolysis on
Columbia agar with sheep blood, were agglutin-
ated with Lancefield group-specific antisera
(Streptocard Enzyme Latex Test; BBL). Red–
orange colonies detected on one medium only
were agglutinated, and were also identified using
the MicroScan system with the Positive Combo
Panel 1S A (Dade International, West Sacramento,
CA, USA). b-Haemolytic colonies, recovered on
Columbia agar containing sheep blood from
samples that failed to yield red–orange colonies
on GM or GBSDA, were also agglutinated with
specific antisera and identified with the Micro-
Scan system. The association of qualitative vari-
ables was evaluated by chi-square test and
Fisher’s exact test.
Overall, GBS isolates were obtained from 53 of
320 swabs, including 52 swabs that yielded red–
orange colonies, 47 of them on both GM and
GBSDA, and a further five only on GBSDA. One
swab was not identified as GBS-positive on either
GBSDA or GM, but only following subculture in
LIM broth. Of the five swabs that yielded a
positive result with GBSDA but not with GM, two
were positive after 24 h, and three were positive
after 48 h. Of the remaining positive swabs, most
yielded red–orange colonies on both GM and GBS
after incubation for 24 h; longer periods of incu-
bation did not improve the detection of GBS
colonies. No non-haemolytic GBS strains were
detected, but control (non-clinical) GBS strains
that were weakly b-haemolytic on sheep blood
agar were found to be weakly pigmented on GM
and GBSDA, the latter with lighter pigmentation,
Thus, it seems that a blood agar plate should also
be inoculated in order to detect all strains of GBS,
including non-haemolytic strains.
Table 1 summarises the main microbiological
properties of GBS isolates growing on GM and
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GBSDA. Only the difference in colony size was
statistically significant, although GBSDA recov-
ered c. 10% more GBS strains than did GM, and
c. 20% of the isolates had a stronger pigmentation
on GBSDA.
The usefulness of GM for the detection of GBS
has been demonstrated previously [6,9,11]. More-
over, the use of selective broth for the isolation
and detection of GBS has been reported to have
good sensitivity, although the technique is time-
consuming [9]. In the present study, one GBS
isolate was recovered that had failed to be
identified on GM or GBSDA, providing further
evidence that, although time-consuming, this is a
sensitive method for recovering S. agalactiae. Since
swabs were inoculated into LIM broth only after
the GM and GBSDA plates were inoculated, the
sensitivity may have been underestimated. How-
ever, the cost of screening is higher if the
enrichment procedure is used.
There are advantages in the use of GBSDA rather
than GM, in that the intensity of colony pigmen-
tation on GBSDA is stronger, the saprophytic flora
is more suppressed, and GBSDA may be more
sensitive, although the differences were not statis-
tically significant in the present study. The time
and costs involved are similar to those required for
GM, and less than those required for the LIM broth
enrichment method. It was therefore concluded
that GBSDA is a valid alternative to GM for the
isolation and detection of S. agalactiae from preg-
nant women.
REFERENCES
1. Baker CJ, Edwards MS. Group B streptococcal infections.
In: Remington J, Klein JO, eds. Infectious diseases of the fetus
and newborn infant, 4th edn. Philadelphia: WB Saunders,
1995; 980–1054.
2. Centers for Disease Control and Prevention. Prevention of
perinatal group B streptococcal disease. MMWR 2002;
51(RR11): 1–22.
3. De la Rosa M, Villareal R, Vega D, Miranda C, Martinez
Brocal A. Granada medium for detection and identification
of group B streptococci. J Clin Microbiol 1983; 18: 779–785.
4. Islam AK. Rapid recognition of group B streptococci.
Lancet 1977; 1: 256–257.
5. De la Rosa M, Perez M, Carazo C, Pareja L, Peis JI, Her-
nandez F. New Granada medium for detection and iden-
tification of group B streptococci. J Clin Microbiol 1992; 30:
1019–1021.
6. Garcia Gil E, Rodrı´guez MC, Bartolome´ R, Berjano B,
Cabero L, Andreu A. Evaluation of the Granada agar plate
for detection of vaginal and rectal group B streptococci in
pregnant women. J Clin Microbiol 1999; 37: 2648–2651.
7. Claeys G, Verschaegen G, Temmerman M. Modified Gra-
nada agar medium for the detection of group B strepto-
coccus carriage in pregnant women. Clin Microbiol Infect
2001; 7: 22–24.
8. Kelly VN, Garland SM. Evaluation of new Granada
(modified) for the antenatal detection of group B strepto-
coccus. Pathology 1994; 26: 487–489.
9. Rosa-Fraile M, Rodrı´guez-Granger J, Cueto-Lopez M et al.
Use of Granada medium to detect group B streptococcal
colonization in pregnant women. J Clin Microbiol 1999; 37:
2674–2677.
10. Overman SB, Eley DD, Jacobs BE, Ribes JA. Evaluation
of methods to increase the sensitivity and timeliness of
detection of Streptococcus agalactiae in pregnant women.
J Clin Microbiol 2002; 40: 4329–4331.
11. De la Rosa-Fraile M. Granada agar sensitivity and detec-
tion of group B Streptococcus. J Clin Microbiol 2003; 41:
4007.
Table 1. Microbiological properties of swabs yielding
positive results on Granada medium (GM) and Group B
Streptococcus Differential Agar (GBSDA)
% swabs positive on
GM GBSDA pa
Growth scoreb
NG 11.3 1.8 0.294
+ 45.3 60.4
++ 18.9 15.1
+++ 17 17.0
++++ 7.5 5.7
Pigmentation (%)
Yellow 4.2 1.9 0.084
Pale orange 15.0 5.7
Orange 48.9 38.4
Deep orange 31.9 54.0
Colony diameter
< 1 mm 44.7 80.8 < 0.001
1–2 mm 55.3 19.2
> 2 mm 0 0
Growth of saprophytesc
VR 35.9 47.2 0.460
+ 33.9 35.9
++ 18.9 9.4
+++ 9.4 7.5
++++ 1.9 0
ap values in bold are statistically significant.
b+, weak growth, usually < 10 CFU; ++, moderate growth, usually 10–100 CFU;
+++, high growth, usually between 100 and 1000 CFU; ++++, very high growth,
innumerable colonies; NG, no growth.
c The presence of contaminant saprophytic flora: < 10 CFU, very rare (VR); +, ‡
10 CFU but only in the first quadrant of the plate; ++, colonies reaching the second
quadrant of the plate; ++, colonies reaching the third quadrant of the plate; +++,
colonies reaching the fourth quadrant of the plate.
678 Clinical Microbiology and Infection, Volume 11 Number 8, August 2005
 2005 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 11, 670–681
